Global Mycoplasma Testing Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends
3 Jun, 2021
The mycoplasma testing market consists of sales of mycoplasma testing services and related products by entities (organizations, sole traders, and partnerships) that provide mycoplasma testing to detect mycoplasma pneumonia, which causes mycoplasma pneumonia. Mycoplasma pneumonia is a contagious respiratory infection that spreads easily through contact with respiratory fluids. It can cause epidemics. Mycoplasma testing includes a group of tests that measures antibodies in the blood produced in response to a mycoplasma infection and detects the microbe directly through detecting or culturing its genetic material (DNA) in a body sample.
Global Mycoplasma Testing Market Size And Drivers:
The global mycoplasma testing market is expected to grow from $0.64 billion in 2020 to $0.72 billion in 2021 at a compound annual growth rate (CAGR) of 12.4%. The growth is mainly due to a growing demand for these types of tests owing to an increase in spread of mycoplasma pneumonia. The mycoplasma testing market is expected to reach $1.14 billion in 2025 at a CAGR of 12.38%. The prevalence of mycoplasma pneumonia co-infection among patients with COVID-19 is expected to boost the market for mycoplasma testing in the forecast period.
Request For A Sample For The Global Mycoplasma Testing Market Report:
Trends In The Global Mycoplasma Testing Market
Major players operating in the market are undertaking various strategic investments such as the launch of innovative products, research and development advancements, and technological innovations, which are gaining significant popularity in the mycoplasma testing market. Companies are introducing new innovative products to meet the requirements of end-users and expand the consumer base to survive in the competitive business environment. For instance, in July 2020, BioMérieux, a France-based biotechnology company introduced Bio Fire Mycoplasma, an advanced test used for bio-therapeutics including hormones, antibodies, gene, and cell therapies for mycoplasma detection in pharmaceutical products.
Global Mycoplasma Testing Market Segments::
The global mycoplasma testing market is further segmented based on product, technology, application, end user and geography.
By Product: Instruments, Assay, Kits, and Reagents
By Technology: PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies
By Application: Cell Line Testing, Virus Testing, End-of-Production Cell Testing
By End User: Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes
By Geography: The global mycoplasma testing market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the mycoplasma testing market in 2020.
Read More On The Report For The Global Mycoplasma Testing Market At:https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report
Mycoplasma Testing Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides mycoplasma testing market overviews, analyzes and forecasts market size and growth for the global mycoplasma testing market, mycoplasma testing market share, mycoplasma testing market players, mycoplasma testing market segments and geographies, mycoplasma testing market’s leading competitors’ revenues, profiles and market shares. The mycoplasma testing market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.